BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

757 related articles for article (PubMed ID: 10438978)

  • 1. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies.
    Liang B; Gee RJ; Kashgarian MJ; Sharpe AH; Mamula MJ
    J Immunol; 1999 Aug; 163(4):2322-9. PubMed ID: 10438978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibody responses and pathology regulated by B7-1 and B7-2 costimulation in MRL/lpr lupus.
    Liang B; Kashgarian MJ; Sharpe AH; Mamula MJ
    J Immunol; 2000 Sep; 165(6):3436-43. PubMed ID: 10975864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule.
    Nakajima A; Azuma M; Kodera S; Nuriya S; Terashi A; Abe M; Hirose S; Shirai T; Yagita H; Okumura K
    Eur J Immunol; 1995 Nov; 25(11):3060-9. PubMed ID: 7489744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus.
    Lartigue A; Colliou N; Calbo S; François A; Jacquot S; Arnoult C; Tron F; Gilbert D; Musette P
    J Immunol; 2009 Nov; 183(10):6207-16. PubMed ID: 19841185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversing interleukin-2 inhibition mediated by anti-double-stranded DNA autoantibody ameliorates glomerulonephritis in MRL-lpr/lpr mice.
    Song YC; Tang SJ; Lee TP; Hung WC; Lin SC; Tsai CY; Ng WV; Wu MF; Sun KH
    Arthritis Rheum; 2010 Aug; 62(8):2401-11. PubMed ID: 20506162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune lpr/lpr mice deficient in CD40 ligand: spontaneous Ig class switching with dichotomy of autoantibody responses.
    Ma J; Xu J; Madaio MP; Peng Q; Zhang J; Grewal IS; Flavell RA; Craft J
    J Immunol; 1996 Jul; 157(1):417-26. PubMed ID: 8683147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRL mice produce anti-Su autoantibody, a specificity associated with systemic lupus erythematosus.
    Treadwell EL; Cohen P; Williams D; O'Brien K; Volkman A; Eisenberg R
    J Immunol; 1993 Jan; 150(2):695-9. PubMed ID: 8419494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of lupus-associated autoantibodies by immunization with native and recombinant Ig polypeptides expressing a cross-reactive idiotype 4B4.
    Dang H; Ogawa N; Takei M; Lazaridis K; Talal N
    J Immunol; 1993 Dec; 151(12):7260-7. PubMed ID: 8258723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of B7-1 and B7-2 costimulation for the generation of CTL responses in vivo.
    Sigal LJ; Reiser H; Rock KL
    J Immunol; 1998 Sep; 161(6):2740-5. PubMed ID: 9743331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of a positive feedback mechanism in the anti-Sm autoantibody response of MRL/MPJ-lpr/lpr mice.
    Stocks MR; Williams DG; Maini RN
    Eur J Immunol; 1991 Feb; 21(2):267-72. PubMed ID: 1999219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell autoimmunity in Ig transgenic mice.
    Shinde S; Gee R; Santulli-Marotto S; Bockenstedt LK; Clarke SH; Mamula MJ
    J Immunol; 1999 Jun; 162(12):7519-24. PubMed ID: 10358207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of anti-Sm autoantibodies by the immunoglobulin heavy chain locus.
    Halpern MD; Craven SY; Cohen PL; Eisenberg RA
    J Immunol; 1993 Dec; 151(12):7268-72. PubMed ID: 8258724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
    Yajima K; Nakamura A; Sugahara A; Takai T
    Eur J Immunol; 2003 Apr; 33(4):1020-9. PubMed ID: 12672068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overlap of the anti-Sm and anti-DNA responses of MRL/Mp-lpr/lpr mice.
    Bloom DD; Davignon JL; Cohen PL; Eisenberg RA; Clarke SH
    J Immunol; 1993 Feb; 150(4):1579-90. PubMed ID: 8432994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of anti-B7 monoclonal antibodies on humoral immune responses.
    Daikh DI; Wofsy D
    J Autoimmun; 1999 Mar; 12(2):101-8. PubMed ID: 10047430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
    J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emergence of anti-dsDNA antibodies precedes nucleosome-specific antibodies in MRL/lpr and MRL/+ mice.
    Lu Q; Kanai Y; Kubota T
    J Med Dent Sci; 2003 Mar; 50(1):9-15. PubMed ID: 12715914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus.
    Gu L; Weinreb A; Wang XP; Zack DJ; Qiao JH; Weisbart R; Lusis AJ
    J Immunol; 1998 Dec; 161(12):6999-7006. PubMed ID: 9862736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of the autoimmune Yaa and lpr genes on the acceleration of lupus-like syndrome in MRL/MpJ mice.
    Merino R; Shibata T; De Kossodo S; Izui S
    Eur J Immunol; 1989 Nov; 19(11):2131-7. PubMed ID: 2599002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) down-regulates induction of contact sensitivity by haptenated epidermal cells.
    Katayama I; Matsunaga T; Yokozeki H; Nishioka K
    Br J Dermatol; 1997 Jun; 136(6):846-52. PubMed ID: 9217815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.